Reference:

Keyword:
Issue date:
From:
To:
Originator: (For multiple select: Ctrl key + Click)



Reference Alert Title Originated ByIssue DateStatus
SDA/2021/001 Methylprednisolone powder for solution for injection (all strengths) - Supply disruption DHSC & NHS England and Improvement: Supply disruption alert 14-Jan-2021 Issued
CEM/CMO/2021/002 Supporting doctors throughout the COVID-19 pandemic CMO Messaging 12-Jan-2021 Issued
CEM/CMO/2021/001 COVID-19 Therapeutic Alert: Interleukin-6 inhibitors (tocilizumab or sarilumab) for patients admitte ... CMO Messaging 08-Jan-2021 Issued
SDA/2020/012(U2) Lithium carbonate (Priadel) 200mg and 400mg tablets - Supply Disruption Update DHSC & NHS England and Improvement: Supply disruption alert 04-Jan-2021 Issued
CEM/CMO/2020/044 Letter from the UK Chief Medical Officers regarding the UK COVID-19 vaccination programmes CMO Messaging 31-Dec-2020 Issued
EL (20)A/61 CLASS 2 DRUG ALERT, ACTION WITHIN 48 HOURS, MEDAC GMBH (T/A MEDAC PHARMA LLP), SODIOFOLIN 50MG/ML SO ... MHRA Drug Alerts 29-Dec-2020 Issued
CEM/CMO/2020/043 Immediate Actions in response to SARS-CoV-2 virus new variants of concerns CMO Messaging 24-Dec-2020 Issued
CEM/CMO/2020/042 Therapeutic Anticoagulation (Heparin) in the Management of Severe COVID-19 (SARS-CoV-2 Positive) Pat ... CMO Messaging 23-Dec-2020 Issued
CEM/CMO/2020/041 Indemnity arrangements for the Covid-19 vaccination programme CMO Messaging 23-Dec-2020 Issued
EL (20)A/60 CLASS 2 DRUG ALERT, ACTION WITHIN 48 HOURS, MERCK SHARP & DOHME LIMITED, ZERBAXA 1G/0.5G POWDER ... MHRA Drug Alerts 16-Dec-2020 Issued
12345678910...


* Alerts highlighted in blue are National Patient Safety Alerts. Further information about this type of alert can be found in this update.

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency